Mairena Martín

Prof. Mairena Martín

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
RGRamon Guixà-González
Ramon Guixà-González
JAJosé L. Albasanz
José L. Albasanz
IEIsmael Rodríguez Espigares
Ismael Rodríguez Espigares
MPManuel Pastor
Manuel Pastor
FSFerran Sanz
Ferran Sanz
JSJana Selent
Jana Selent
Cholesterol is a key component of cell membranes with a proven modulatory role on the function and ligand-binding properties of G-protein-coupled receptors (GPCRs). Crystal structures of prototypical GPCRs such as the adenosine A2A receptor (A2AR) have confirmed that cholesterol finds stable binding sites at the receptor surface suggesting an allosteric role of this lipid. Here we combine experimental and computational approaches to show that cholesterol can spontaneously enter the A2AR-binding pocket from the membrane milieu using the same portal gate previously suggested for opsin ligands. We confirm the presence of cholesterol inside the receptor by chemical modification of the A2AR interior in a biotinylation assay. Overall, we show that cholesterol’s impact on A2AR-binding affinity goes beyond pure allosteric modulation and unveils a new interaction mode between cholesterol and the A2AR that could potentially apply to other GPCRs.

31 January 2008 in Brain Pathology
Verified
Journal Article
Closed access
JAJosé Luis Albasanz
José Luis Albasanz
SPSandra Perez
Sandra Perez
MBMarta Barrachina
Marta Barrachina
IFIsidro Ferrer
Isidro Ferrer
MMMairena Martín
Mairena Martín

6 February 2013 in NeuroMolecular Medicine
Verified
Journal Article
Closed access
PDF file
IVIzaskun Villar-Menéndez
Izaskun Villar-Menéndez
MBMarta Blanch
Marta Blanch
STShiraz Tyebji
Shiraz Tyebji
TPThais Pereira-Veiga
Thais Pereira-Veiga
JAJosé Luis Albasanz
José Luis Albasanz
MBMarta Barrachina
Marta Barrachina

1 September 2014 in Neurobiology of Disease
Verified
Journal Article
Closed access
IVIzaskun Villar-Menéndez
Izaskun Villar-Menéndez
SPSílvia Porta
Sílvia Porta
SBSandra P. Buira
Sandra P. Buira
TPThais Pereira-Veiga
Thais Pereira-Veiga
SDSara Díaz-Sánchez
Sara Díaz-Sánchez
MBMarta Barrachina
Marta Barrachina


21 February 2018 in Brain Pathology
Verified
Journal Article
Open access
PAPatricia Alonso‐Andrés
Patricia Alonso‐Andrés
JAJosé Luis Albasanz
José Luis Albasanz
Isidro FerrerIsidro Ferrer
Isidro Ferrer
MMMairena Martín
Mairena Martín
Adenosine, hypoxanthine, xanthine, guanosine and inosine levels were assessed by HPLC, and the activity of related enzymes 5′‐nucleotidase (5′‐NT), adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) measured in frontal (FC), parietal (PC) and temporal (TC) cortices at different stages of disease progression in Alzheimer's disease (AD) and in age‐matched controls. Significantly decreased levels of adenosine, guanosine, hypoxanthine and xanthine, and apparently less inosine, are found in FC from the early stages of AD; PC and TC show an opposing pattern, as adenosine, guanosine and inosine are significantly increased at least at determinate stages of AD whereas hypoxanthine and xanthine levels remain unaltered. 5′‐NT is reduced in membranes and cytosol in FC mainly at early stages but not in PC, and only at advanced stages in cytosol in TC. ADA activity is decreased in AD when considered as a whole but increased at early stages in TC. Finally, PNP activity is increased only in TC at early stages. Purine metabolism alterations occur at early stages of AD independently of neurofibrillary tangles and β‐amyloid plaques. Alterations are stage dependent and region dependent, the latter showing opposite patterns in FC compared with PC and TC. Adenosine is the most affected of the assessed purines.